ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Study on the Potential Mechanism of Tonifying Kidney and Removing Dampness Formula in the Treatment of Postmenopausal Dyslipidemia Based on Network Pharmacology, Molecular Docking and Experimental Evidence

Li, Xuewen; Chen, Hongyan; Yang, Hongyan; Liu, Jian; Li, Yang; Dang, Yue; Wang, Jiajing; Wang, Lei; Li, Jun*; Nie, Guangning*广州中医药大学
Frontiers in Endocrinology2022-7-7DOI: 10.3389/fendo.2022.918469
5被引21阅读
引用收藏
分享

摘要

BackgroundManagement of menopausal dyslipidemia is the main measure to reduce the incidence of cardiovascular disease in postmenopausal women. Tonifying Kidney and Removing Dampness Formula (TKRDF) is a traditional Chinese medicine (TCM) formula that ameliorates dyslipidemia in postmenopausal women. This study applied network pharmacology, molecular docking, and in vitro and in vitro experiments to investigate the underlying mechanism of TKRDF against postmenopausal dyslipidemia. MethodsNetwork pharmacology research was first conducted, and the active compounds and targets of TKRDF, as well as the targets of postmenopausal dyslipidemia, were extracted from public databases. Protein-protein interaction (PPI), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were used to identify the potential targets and signaling pathways of TKRDF in postmenopausal dyslipidemia. Molecular docking was then performed to evaluate the combination of active compounds with principal targets. Finally, an ovariectomized rat model was used for the in vivo experiment and alpha mouse liver 12 (AML12) cells treated with palmitic acid were used for the in vitro experiments to provide further evidence for the research. ResultsBased on network pharmacology analysis, we obtained 78 active compounds from TKRDF that acted on 222 targets of postmenopausal dyslipidemia. The analysis results indicated that IL6, TNF, VEGFA, AKT1, MAPK3, MAPK1, PPARG and PIK3CA, etc., were the potentially key targets, and the PI3K/AKT signaling pathway was the possibly crucial pathway for TKRDF to treat postmenopausal dyslipidemia. Molecular docking suggested that the active compounds have good binding activity with the core targets. The in vivo and in vitro experiments demonstrated that TKRDF ameliorates postmenopausal dyslipidemia by regulating hormone levels, inhibiting inflammation, promoting angiogenesis and inhibiting lipid synthesis, which appear to be related to TKRDF's regulation of the ERK1/2 and PI3K/AKT signaling pathways. ConclusionThis study clarified the active ingredients, potential targets, and molecular mechanisms of TKRDF for treating postmenopausal dyslipidemia. It also provided a feasible method to uncover the scientific basis and therapeutic mechanism for prescribing TCM in the treatment of diseases.

学科与关键词

关键词
TCMpostmenopausal dyslipidemiatonifying kidney and removing dampness formulanetwork pharmacologymolecular dockingpharmacological mechanisms
相关
加载中…
  • Network pharmacology analysis of molecular targets and related mechanisms of Guizhi decoction in treating of menopausal syndrome
    Zhang, Qian; Liang, Jingtao; Zhou, Ying*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2022, 101(29): e29453.被引 2
  • Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology
    Gong, Zhaohui; Li, Rong; Chen, Shulin; Wu, Hui; Cai, Yinhe; Li, Junlong; Zhao, Xinjun; Chu, Qingmin; Luo, Chuanjin; Qing, Lijin; Li, Nan*; Wu, Wei*Journal of Healthcare Engineering, 2022, 2022: 2457706.被引 2
  • Network Pharmacological Study on Mechanism of the Therapeutic Effect of Modified Duhuo Jisheng Decoction in Osteoporosis
    Huang, Xudong; Zhou, Zhou; Zheng, Yingyi; Fan, Guoshuai; Ni, Baihe; Liu, Meichen; Zhao, Minghua; Zeng, Lingfeng*; Wang, Weiguo*Frontiers in Endocrinology, 2022, 13: 860649.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Endocrinology
发表日期
2022-07-07
卷期
第 13 卷
页码
918469
DOI
10.3389/fendo.2022.918469
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81804132]; Guangdong Basic and Applied Basic Research Foundation [2022A1515011651, 2021A1515220139, 2021A1515012573]; Science and Technology Foundation of Guangzhou City [202102010257]; State Key Laboratory of Dampness Syndrome of Chinese Medicine Research Foundation [SZ2021ZZ21, SZ2021ZZ47]; Research Fund for Bajian Talents of Guangdong Provincial Hospital of Chinese Medicine [BJ2022KY09]; Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine [YN2019MJ15]; Scientific research projects of Guangdong Bureau of traditional Chinese Medicine [20222086]

作者

  • L

    Li, Xuewen (第一作者)

    2 · guangzhou univ chinese med

  • C

    Chen, Hongyan

    2 · guangzhou univ chinese med

查看全部 10 位作者收起作者
  • Y

    Yang, Hongyan

    2 · guangzhou univ chinese med

  • L

    Liu, Jian

    2 · guangzhou univ chinese med

  • L

    Li, Yang

    2 · guangzhou univ chinese med

  • D

    Dang, Yue

    shenyang pharmaceut univ

  • W

    Wang, Jiajing

    2 · guangzhou univ chinese med

  • W

    Wang, Lei

    2 · guangzhou univ chinese med

  • L

    Li, Jun (通讯)

    2 · guangzhou univ chinese med

  • N

    Nie, Guangning (通讯)

    2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417